Immune checkpoint inhibitors and timing of administration - Authors' reply.
Lancet Oncol
; 23(2): e57, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-35114126
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immune Checkpoint Inhibitors
/
Antibodies, Monoclonal
Limits:
Humans
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom